Organization | Field Name | ID | Required |
---|---|---|---|
KCR | Tumor Marker 2 (TumorMarker2) | 30350 | no |
NAACCR | Tumor Marker 2 | no |
Field Length: 1
For cases diagnosed on or after January 1, 2004, tumor markers are collected in the Collaborative Stage Site Specific Factors fields and not in this data field. For earlier diagnoses, this table lists the sites for which tumor marker 2 is collected.
SITE | MARKER |
---|---|
Breast (C50.0-50.9) | Progesterone Receptor Assay (PRA) |
Prostate (C61.9) | Prostatic Specific Antigen (PSA) |
Testis (C62.0, C62.1, C62.9) | Human chorionic gonadotropin (hCG) Range 1 <5,000 mIU/ml Range 2 5,000 - 50,000 mIU/ml Range 3 >50,000 mIU/ml |
Code | Description |
---|---|
0 | None done (test was not ordered and was not performed) |
1 | Positive/Elevated (breast and prostate only) |
2 | Negative/Normal |
3 | Borderline, undetermined whether positive or negative (breast and prostate only) |
4 | Range 1 (testis only, AFP, See Table) |
5 | Range 2 (testis only, AFP, See Table) |
6 | Range 3 (testis only, AFP, See Table) |
8 | Ordered, but results not in chart; or results not convertible to Range 1, 2, or 3 |
9 | Unknown or no information (all sites other than those specified in the table) |
Testicular Cancer
Acceptable codes for testicular cancer are 0, 2, 4, 5, 6, 8, 9. For testis cases only, record the Human Chorionic Gonadotropin (hCG) in Tumor Marker 2. If there are serial serum tumor markers, record the lowest (nadir) value of hCG after orchiectomy in the first course of treatment.